Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Workflow Type, By Type, By Source Of Isolation, By Indication, By Application, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-4-68039-361-1
- Number of Pages: 120
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Mesenchymal Stem Cells Products & Services Outlook (Revenue, USD Million, 2018 - 2030)
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Mesenchymal Stem Cells Workflow Type Outlook (Revenue, USD Million, 2018 - 2030)
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Mesenchymal Stem Cells Type Outlook (Revenue, USD Million, 2018 - 2030)
- Autologous
- Allogenic
- Mesenchymal Stem Cells Source of Isolation Outlook (Revenue, USD Million, 2018 - 2030)
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Mesenchymal Stem Cells Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Mesenchymal Stem Cells Application Outlook (Revenue, USD Million; 2018 - 2030)
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Mesenchymal Stem Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- North America Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- North America Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- North America Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- North America Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- North America Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- U.S.
- U.S. Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- U.S. Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- U.S. Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- U.S. Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- U.S. Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- U.S. Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- U.S. Mesenchymal Stem Cells Market, By Products & Services
- Canada
- Canada Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Canada Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Canada Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Canada Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Canada Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Canada Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Canada Mesenchymal Stem Cells Market, By Products & Services
- North America Mesenchymal Stem Cells Market, By Products & Services
- Europe
- Europe Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Europe Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Europe Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Europe Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Europe Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Europe Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Germany
- Germany Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Germany Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Germany Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Germany Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Germany Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Germany Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Germany Mesenchymal Stem Cells Market, By Products & Services
- UK
- UK Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- UK Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- UK Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- UK Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- UK Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- UK Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- UK Mesenchymal Stem Cells Market, By Products & Services
- France
- France Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- France Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- France Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- France Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- France Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- France Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- France Mesenchymal Stem Cells Market, By Products & Services
- Italy
- Italy Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Italy Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Italy Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Italy Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Italy Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Italy Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Italy Mesenchymal Stem Cells Market, By Products & Services
- Spain
- Spain Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Spain Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Spain Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Spain Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Spain Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Spain Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Spain Mesenchymal Stem Cells Market, By Products & Services
- Denmark
- Denmark Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Denmark Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Denmark Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Denmark Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Denmark Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Denmark Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Denmark Mesenchymal Stem Cells Market, By Products & Services
- Sweden
- Sweden Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Sweden Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Sweden Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Sweden Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Sweden Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Sweden Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Sweden Mesenchymal Stem Cells Market, By Products & Services
- Norway
- Norway Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Norway Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Norway Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Norway Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Norway Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Norway Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Norway Mesenchymal Stem Cells Market, By Products & Services
- Europe Mesenchymal Stem Cells Market, By Products & Services
- Asia Pacific
- Asia Pacific Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Asia Pacific Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Asia Pacific Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Asia Pacific Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Asia Pacific Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Asia PacificMesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- China
- China Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- China Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- China Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- China Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- China Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- China Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- China Mesenchymal Stem Cells Market, By Products & Services
- Japan
- Japan Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Japan Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Japan Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Japan Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Japan Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Japan Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Japan Mesenchymal Stem Cells Market, By Products & Services
- India
- India Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- India Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- India Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- India Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- India Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- India Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- India Mesenchymal Stem Cells Market, By Products & Services
- South Korea
- South Korea Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- South Korea Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- South Korea Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- South Korea Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- South Korea Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- South Korea Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- South Korea Mesenchymal Stem Cells Market, By Products & Services
- Australia
- Australia Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Australia Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Australia Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Australia Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Australia Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Australia Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Australia Mesenchymal Stem Cells Market, By Products & Services
- Thailand
- Thailand Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Thailand Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Thailand Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Thailand Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Thailand Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Thailand Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Thailand Mesenchymal Stem Cells Market, By Products & Services
- Asia Pacific Mesenchymal Stem Cells Market, By Products & Services
- Latin America
- Latin America Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Latin America Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Latin America Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Latin America Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Latin America Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Latin America Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Brazil
- Brazil Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Brazil Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Brazil Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Brazil Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Brazil Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Brazil Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Brazil Mesenchymal Stem Cells Market, By Products & Services
- Mexico
- Mexico Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Mexico Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Mexico Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Mexico Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Mexico Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Mexico Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Mexico Mesenchymal Stem Cells Market, By Products & Services
- Argentina
- Argentina Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Argentina Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Argentina Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Argentina Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Argentina Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Argentina Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Argentina Mesenchymal Stem Cells Market, By Products & Services
- Latin America Mesenchymal Stem Cells Market, By Products & Services
- Middle East and Africa (MEA)
- Middle East and Africa (MEA) Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Middle East and Africa (MEA) Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Middle East and Africa (MEA) Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Middle East and Africa (MEA) Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Middle East and Africa (MEA) Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Middle East and Africa (MEA) Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- South Africa
- South Africa Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- South Africa Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- South Africa Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- South Africa Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- South Africa Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- South Africa Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- South Africa Mesenchymal Stem Cells Market, By Products & Services
- Saudi Arabia
- Saudi Arabia Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Saudi Arabia Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Saudi Arabia Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Saudi Arabia Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Saudi Arabia Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Saudi Arabia Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Saudi Arabia Mesenchymal Stem Cells Market, By Products & Services
- UAE
- UAE Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- UAE Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- UAE Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- UAE Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- UAE Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- UAE Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- UAE Mesenchymal Stem Cells Market, By Products & Services
- Kuwait
- Kuwait Mesenchymal Stem Cells Market, By Products & Services
- Products
- Cells & cell lines
- Kits, media, & reagents
- Others
- Services
- Products
- Kuwait Mesenchymal Stem Cells Market, By Workflow Type
- Cell sourcing & isolation
- Culture & cryopreservation
- Differentiation
- Characterization
- Kuwait Mesenchymal Stem Cells Market, By Type
- Autologous
- Allogenic
- Kuwait Mesenchymal Stem Cells Market, By Source of Isolation
- Bone marrow
- Cord blood
- Peripheral blood
- Fallopian tube
- Fetal liver
- Lung
- Adipose tissues
- Kuwait Mesenchymal Stem Cells Market, By Indication
- Bone and cartilage repair
- Cardiovascular diseases
- Inflammatory and immunological diseases
- Liver diseases
- Cancer
- GvHD
- Others
- Kuwait Mesenchymal Stem Cells Market, By Application
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- Others
- Kuwait Mesenchymal Stem Cells Market, By Products & Services
- Middle East and Africa (MEA) Mesenchymal Stem Cells Market, By Products & Services
- North America
Mesenchymal Stem Cells Market Dynamics
Driver: Expanding Pipeline and Clinical Studies of Mesenchymal Stem Cell (MSC) Based Products
The strong pipeline of Mesenchymal Stem Cells (MSC)-based products is recognized as a vital factor driving the global mesenchymal stem cell market. As of 2023, ten MSC-based products have achieved approval from regulatory bodies around the world. These approved products include nine products for cell therapy and one for tissue engineering. Thus, the growing number of approvals for pipeline MSC products is likely to drive the market in the upcoming years. Furthermore, increasing confidence in the safety and efficacy of MSCs is reflected in the growing number of clinical trials and research initiatives dedicated to using the regenerative capabilities of MSCs. In addition, the versatility of MSCs in being sourced from various tissues, such as bone marrow, adipose tissue, and umbilical cord, adds to their attractiveness for therapeutic development, allowing for tailored approaches to different medical conditions. According to an NCBI article published in July 2020, over 1,050 clinical trials focusing on the potential of MSCs have been registered with the U.S. FDA. Moreover, a rising number of companies have either already commercialized or are in the process of commercializing therapies based on MSCs. For instance, Takeda/TiGenix phase 3 clinical trial incorporates MSCs for complex perianal fistulas in Crohn's disease. This was the most successful late-stage clinical trial, as of September 2020. The therapeutic product, Alofisel, received approval from the EU in 2018. In addition, Mesoblast has examined the use of remestemcel-L, an MSC-based product, for the treatment of COVID-19 patients. These factors are expected to drive the global market for MSCs.
Driver: Emerging Applications of MSCS
The versatility of MSCs has increased their use in therapeutic settings. In addition to the use of MSCs in regenerative medicine and tissue engineering, scientists are exploring their potential in the treatment of various diseases, including cancer. Several clinical trials are being conducted to test the efficacy and safety of MSCs in diseases such as graft versus host disease, cerebral palsy, systemic lupus erythematous, type1 diabetes, and rheumatoid arthritis. Besides these indications, MSCs are being evaluated for the treatment of COVID-19. According to data available on clinicaltrials.gov, 70 clinical trials have been described that are using MSCs in response to the SARS-CoV-2 pandemic. For instance, in April 2020, a team of U.S. researchers received FDA approval to initiate a clinical trial for the evaluation of umbilical cord-derived MSCs to prevent lung inflammation in severe COVID-19 cases. Thus, the expanding landscape of MSC therapies is anticipated to fuel the market growth. Furthermore, as of July 2022, 40 clinical trials have been registered that employ MSCs in various cancer conditions. These studies assess the efficacy and safety of MSC applications in cancer patients. Out of these studies, 62% of MSC trials are for therapeutic purposes to decrease the adverse effects of cancer treatments. Moreover, owing to their tropism-where these cells can direct themselves toward the tumor site-MSCs are a promising vector to deliver antitumor agents. Genetically modified MSCs can be an effective therapeutic tool due to an upsurge in tropism to the tumor. Furthermore, these cells can selectively migrate toward the tumour and exert therapeutic effects to significantly increase concentration. Thus, the problems related to pronounced toxicity and half-life of agents are minimized with the application of MSCs
Restraint: Lack of Standardized & Regulated Delivery of Stem Cell Therapy
MSCs have shown remarkable potential in scientific research and clinical applications. However, the intricacies of cell replacement and tissue repair mechanisms can hamper the extensive acceptance of MSCs in the global market. Moreover, medical tourism and unregulated stem cell clinics are endorsing unapproved stem cell therapies, leading to inappropriate or even harmful delivery of these advanced treatments. Countries such as China, Mexico, and Argentina have witnessed an increase in unregulated clinics offering stem cell treatments for various ailments, including Alzheimer's disease, muscular dystrophy, spinal cord injury, and Parkinson's disease. In April 2021, the University of Texas Health Science Center at Houston (UTHealth) initiated a Phase II clinical trial to evaluate the effectiveness of mesenchymal adult stem cells as a potential disease-modifying therapy for Parkinson's disease. Such unsanctioned and unregulated practices of administering stem cell therapy could hinder the growth of the mesenchymal stem cell market. The disconnect between premature public marketing of stem cell products and reputable clinical trials has expanded the gap between approved therapies and clinics offering unregulated therapies, creating confusion and apprehension among potential patients. In March 2019, the U.S. FDA issued a warning regarding the issue of using unproven stem cell therapies owing to the growing tendency of people to undergo potentially harmful and illegal stem cell treatments.
What Does This Report Include?
This section will provide insights into the contents included in this mesenchymal stem cells market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Mesenchymal stem cells market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Mesenchymal stem cells market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
